MedPath

CEFZIL POWDER FOR ORAL SUSPENSION-250 MG/ 5 ML

CEFZIL POWDER FOR ORAL SUSPENSION-250 MG/ 5 ML

Discontinued
DIN Number

02163683

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02163683
AIG Number0127613004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DC10 CEFPROZIL
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationOral
AHFS Classification08:12.06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFPROZILActive
Strength: 250 MG / 5 ML
Monograph: CEFPROZIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.